Biologics, Biotech Basics, Cancer, Clinical Trials, Drug Development, Drug Targets, Mechanism of Action, Monoclonal Antibodies, Orphan Disease, Orphan Drugs / May 25, 2017

Nanobodies: These Are Not Your Mother’s mAbs

View Post

Biologics, Biotech Basics, Cancer, Clinical Trials, Drug Development, Drug Targets, Easily Confused, Mechanism of Action, Monoclonal Antibodies, Small Molecule Drugs / March 9, 2017

Therapeutic Antibody Primer

View Post

Biologics, Biotech Basics, Cancer, Clinical Trials, Drug Development, Drug Targets, Easily Confused, Monoclonal Antibodies, The WEEKLY / May 19, 2016

Hacking The Immune Response

View Post

Cancer, Drug Approvals, FDA, Genetics, Mechanism of Action, Monoclonal Antibodies, Small Molecule Drugs, The WEEKLY / May 12, 2016

Pushing The Self-Destruct Button

View Post

Cancer, Deoxyribonucleic Acid (DNA), Diagnostics, FDA, Monoclonal Antibodies, Ribonucleic Acid (RNA), Term of the Week, The WEEKLY / December 10, 2015

Catching The First Drop Of Cancer

View Post

Biologics, Business of Biotech, Cardiovascular Disease, Clinical Trials, Drug Approvals, Drug Development, Drug Targets, FDA, Mechanism of Action, Monoclonal Antibodies, Ribonucleic Acid (RNA), The WEEKLY / September 2, 2015

RNAi Crashes The PCSK9 Party

View Post

Biologics, Biotech Basics, Business of Biotech, Cancer, Cardiovascular Disease, Clinical Trials, Diabetes, Diagnostics, Drug Approvals, Drug Development, Drug Targets, Ebola, FDA, Genetics, Mechanism of Action, Monoclonal Antibodies, Orphan Disease, Orphan Drugs, Small Molecule Drugs, The WEEKLY / November 25, 2014

12 Biotech Concepts Everyone Should Know

View Post

Biologics, Cancer, Cocktail Fodder, Diagnostics, Monoclonal Antibodies, The WEEKLY / November 6, 2014

Breaking From The Pack With Cancer Diagnostics

View Post

Biologics, Biomanufacturing, Biotech Basics, The WEEKLY / August 14, 2014

Cultivating Biologics From Plants?

View Post

The WEEKLY / April 3, 2014

RNAi Advantage Goes To Dicerna

View Post